Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Widschwendter

Showing results (41-50 of 175) with videos related to

Pageof 18
Sort By:
Breast Cancer Research : BCR|December 3, 2010
Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancerShahab Akhoondi, Linda Lindström, Martin Widschwendter, et al.
Cancer Research|January 7, 2006
Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancerHeidi Fiegl, Simone Millinger, Georg Goebel, et al.
Plos Computational Biology|July 11, 2014
The dynamics of DNA methylation covariation patterns in carcinogenesisAndrew E Teschendorff, Xiaoping Liu, Helena Caren, et al.
Public Health Genomics|September 18, 2018
Ethical, Legal, and Regulatory Issues for the Implementation of Omics-Based Risk Prediction of Women's Cancer: Points to ConsiderEmmanuelle Lévesque, Emily Kirby, Ineke Bolt, et al.
Cancer Research|November 25, 2003
DNA methylation in serum of breast cancer patients: an independent prognostic markerHannes M Müller, Andreas Widschwendter, Heidi Fiegl, et al.
International Journal of Molecular Medicine|August 2, 2011
Loss of imprinting and aberrant methylation of IGF2 in placentas from pregnancies complicated with fetal growth restrictionOurania Koukoura, Stavros Sifakis, Giannoula Soufla, et al.
Clinical Epigenetics|December 15, 2015
The integrative epigenomic-transcriptomic landscape of ER positive breast cancerYang Gao, Allison Jones, Peter A Fasching, et al.
Genome Medicine|October 18, 2022
The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancerJames E Barrett, Karin Sundström, Allison Jones, et al.
Gynecologic Oncology|November 10, 2016
Outcome of patients with advanced ovarian cancer who do not undergo debulking surgery: A single institution retrospective reviewClaudia Marchetti, Rebecca Kristeleit, Mary McCormack, et al.
Genome Medicine|March 29, 2012
Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformationAndrew E Teschendorff, Allison Jones, Heidi Fiegl, et al.
Pageof 18

Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
Breast Cancer Research : BCR|December 3, 2010
Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancerShahab Akhoondi, Linda Lindström, Martin Widschwendter, et al.
Cancer Research|January 7, 2006
Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancerHeidi Fiegl, Simone Millinger, Georg Goebel, et al.
Plos Computational Biology|July 11, 2014
The dynamics of DNA methylation covariation patterns in carcinogenesisAndrew E Teschendorff, Xiaoping Liu, Helena Caren, et al.
Public Health Genomics|September 18, 2018
Ethical, Legal, and Regulatory Issues for the Implementation of Omics-Based Risk Prediction of Women's Cancer: Points to ConsiderEmmanuelle Lévesque, Emily Kirby, Ineke Bolt, et al.
Cancer Research|November 25, 2003
DNA methylation in serum of breast cancer patients: an independent prognostic markerHannes M Müller, Andreas Widschwendter, Heidi Fiegl, et al.
International Journal of Molecular Medicine|August 2, 2011
Loss of imprinting and aberrant methylation of IGF2 in placentas from pregnancies complicated with fetal growth restrictionOurania Koukoura, Stavros Sifakis, Giannoula Soufla, et al.
Clinical Epigenetics|December 15, 2015
The integrative epigenomic-transcriptomic landscape of ER positive breast cancerYang Gao, Allison Jones, Peter A Fasching, et al.
Genome Medicine|October 18, 2022
The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancerJames E Barrett, Karin Sundström, Allison Jones, et al.
Gynecologic Oncology|November 10, 2016
Outcome of patients with advanced ovarian cancer who do not undergo debulking surgery: A single institution retrospective reviewClaudia Marchetti, Rebecca Kristeleit, Mary McCormack, et al.
Genome Medicine|March 29, 2012
Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformationAndrew E Teschendorff, Allison Jones, Heidi Fiegl, et al.
Pageof 18